Home » Topics » BioWorld Science

BioWorld Science
RSS

REGENXBIO offers new interim phase I/IIa data on RGX-314 in wet AMD

May 8, 2019

Durect reports preliminary data from phase IIa study of DUR-928 in alcoholic hepatitis

May 8, 2019

JS Innopharm patents IDO1 and/or TDO inhibitors

May 8, 2019

Jubilant Biosys describes new PADI4 inhibitors

May 8, 2019

Enterprise Therapeutics discloses SCNN1A blockers

May 8, 2019

Japanese researchers present IDO1 and/or TDO inhibitors

May 8, 2019

Merck & Co. patents LRKK2-mutant inhibitors

May 8, 2019

Pilot study of L1-79 demonstrates trends towards improvement in male subjects with ASD

May 8, 2019

First-in-human data presented for IVMED-10 and IVMED-20 for post-cataract inflammation

May 8, 2019

Ocular Therapeutix presents preliminary first-in-human data for OTX-TIC implant

May 8, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...